Title: Rivastigmine for vascular cognitive impairment.
Journal: The Cochrane database of systematic reviews 20130531
Title: Inhibition of human carboxylesterases hCE1 and hiCE by cholinesterase inhibitors.
Journal: Chemico-biological interactions 20130325
Title: A rivastigmine-precipitated manic episode in a patient with Alzheimer-type dementia.
Journal: International psychogeriatrics 20121001
Title: Rivastigmine dermal patch solves eating problems in an individual with advanced Alzheimer's disease.
Journal: Journal of the American Geriatrics Society 20121001
Title: Rivastigmine in the treatment of postoperative delirium: a pilot clinical trial.
Journal: International journal of geriatric psychiatry 20120901
Title: Treatment of delirium following cardiac surgery.
Journal: Journal of cardiac surgery 20120901
Title: Safety and tolerability of rivastigmine transdermal patch formulation in newly diagnosed patients with Alzheimer's dementia in naturalistic conditions.
Journal: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society 20120901
Title: Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20120830
Title: Acetylcholinesterase-inhibiting activity of salicylanilide N-alkylcarbamates and their molecular docking.
Journal: Molecules (Basel, Switzerland) 20120824
Title: Amphiphilic polyaspartamide copolymer-based micelles for rivastigmine delivery to neuronal cells.
Journal: Drug delivery 20120801
Title: Protective role of curcumin on colchicine-induced cognitive dysfunction and oxidative stress in rats.
Journal: Human & experimental toxicology 20120701
Title: Acetylcholinesterase inhibitors and the risk of hip fracture in Alzheimer's disease patients: a case-control study.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20120701
Title: Reduced tissue levels of noradrenaline are associated with behavioral phenotypes of the TgCRND8 mouse model of Alzheimer's disease.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120701
Title: Effect of some medicinal plant extracts on the oxidative stress status in Alzheimer's disease induced in rats.
Journal: European review for medical and pharmacological sciences 20120701
Title: Do local meteorological conditions influence skin irritation caused by transdermal rivastigmine? A retroprospective, pilot study.
Journal: Journal of clinical psychopharmacology 20120601
Title: Estimation of financial burden due to oversupply of medications for chronic diseases.
Journal: Asia-Pacific journal of public health 20120501
Title: Chronic treatment with rivastigmine in patients with Alzheimer's disease: a study on primary motor cortex excitability tested by 5 Hz-repetitive transcranial magnetic stimulation.
Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 20120501
Title: Simultaneous determination of antidementia drugs in human plasma: procedure transfer from HPLC-MS to UPLC-MS/MS.
Journal: Journal of pharmaceutical and biomedical analysis 20120501
Title: Which cholinesterase inhibitor is the safest for the heart in elderly patients with Alzheimer's disease?
Journal: American journal of Alzheimer's disease and other dementias 20120501
Title: Rivastigmine reduces 'Likely to use methamphetamine' in methamphetamine-dependent volunteers.
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20120427
Title: Hallucinations treated with rivastigmine in Creutzfeldt-Jakob disease.
Journal: Fundamental & clinical pharmacology 20120401
Title: New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.
Journal: British journal of clinical pharmacology 20120401
Title: Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease.
Journal: Movement disorders : official journal of the Movement Disorder Society 20120401
Title: Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression.
Journal: The Annals of pharmacotherapy 20120401
Title: Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Journal: The Cochrane database of systematic reviews 20120314
Title: Tissue distribution and pharmacodynamics of rivastigmine after intranasal and intravenous administration in rats.
Journal: Current Alzheimer research 20120301
Title: Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease.
Journal: Cold Spring Harbor perspectives in medicine 20120301
Title: aChE and BuChE inhibition by rivastigmin have no effect on peripheral insulin resistance in elderly patients with Alzheimer disease.
Journal: The journal of nutrition, health & aging 20120201
Title: Development of a capillary electrophoresis-mass spectrometry method for the determination of rivastigmine in human plasma--optimization of the limits of detection and quantitation.
Journal: Electrophoresis 20120201
Title: A fatal outcome after unintentional overdosing of rivastigmine patches.
Journal: Current drug safety 20120201
Title: Acetylcholinesterase inhibitors for schizophrenia.
Journal: The Cochrane database of systematic reviews 20120118
Title: Identification, characterization and quantification of new impurities by LC-ESI/MS/MS and LC-UV methods in rivastigmine tartrate active pharmaceutical ingredient.
Journal: Journal of pharmaceutical and biomedical analysis 20120105
Title: [Pharmacological profile and clinical results of the rivastigmine patch as a new therapeutic agent for Alzheimer's disease].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20120101
Title: Impact of transdermal drug delivery on treatment adherence in patients with Alzheimer's disease.
Journal: Expert review of neurotherapeutics 20120101
Title: Pisa syndrome secondary to rivastigmine: a case report.
Journal: La Clinica terapeutica 20120101
Title: Antioxidant enzymatic activities in Alzheimer's disease: the relationship to acetylcholinesterase inhibitors.
Journal: Journal of Alzheimer's disease : JAD 20120101
Title: The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
Journal: Health technology assessment (Winchester, England) 20120101
Title: [New anti-AD drugs--their possibilities and issues].
Journal: Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20120101
Title: Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia.
Journal: Clinical neuropharmacology 20120101
Title: Concentrations of rivastigmine and NAP 226-90 and the cognitive response in Taiwanese Alzheimer's disease patients.
Journal: Journal of Alzheimer's disease : JAD 20120101
Title: Evaluation of the effects of rivastigmine on cigarette smoking by methamphetamine-dependent volunteers.
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20111201
Title: Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy.
Journal: International journal of geriatric psychiatry 20111201
Title: [Rivastigmine].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20111201
Title: Preparation and evaluation of injectable sustained-release microspheres of rivastigmine.
Journal: Journal of controlled release : official journal of the Controlled Release Society 20111130
Title: Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice.
Journal: Behavioural brain research 20111120
Title: Expressing findings from meta-analyses of continuous outcomes in terms of risks.
Journal: Statistics in medicine 20111110
Title: Effect of cholinergic stimulation in early Alzheimer's disease - functional imaging during a recognition memory task.
Journal: Current Alzheimer research 20111101
Title: BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors.
Journal: European journal of clinical pharmacology 20111101
Title: The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 20111101
Title: Spotlight on rivastigmine transdermal patch: in dementia of the Alzheimer's type.
Journal: Drugs & aging 20111101
Title: Effective pharmacological management of Alzheimer's disease.
Journal: The American journal of managed care 20111101
Title: Pharmacologic treatment for memory disorder in multiple sclerosis.
Journal: The Cochrane database of systematic reviews 20111005
Title: Cholinesterase inhibitor initiation in hospital setting.
Journal: Journal of the American Geriatrics Society 20111001
Title: Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individuals.
Journal: Pharmacology, biochemistry, and behavior 20110901
Title: Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before.
Journal: Expert opinion on investigational drugs 20110901
Title: Effects of cholinesterase inhibitors on postoperative outcomes of older adults with dementia undergoing hip fracture surgery.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20110901
Title: Rivastigmine in Alzheimer's disease and Parkinson's disease dementia: an ADAS-cog factor analysis.
Journal: American journal of Alzheimer's disease and other dementias 20110901
Title: [Newly approved drugs for Alzheimer disease: effectiveness and limitation].
Journal: Brain and nerve = Shinkei kenkyu no shinpo 20110801
Title: New drugs for Alzheimer's disease in Japan.
Journal: Psychiatry and clinical neurosciences 20110801
Title: Bioequivalence evaluation of two brands of rivastigmine of different salt forms, an acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, in healthy Beagle dogs.
Journal: Die Pharmazie 20110801
Title: A case of rivastigmine toxicity caused by transdermal patch.
Journal: The American journal of emergency medicine 20110701
Title: Galantamine (Reminyl) once daily outcome and satisfaction survey (RODOS) in mild to moderate Alzheimer's disease: a study in a real life population.
Journal: Geriatrics & gerontology international 20110701
Title: New perspective for the treatment of Alzheimer diseases: liposomal rivastigmine formulations.
Journal: Drug development and industrial pharmacy 20110701
Title: [Daily functioning in dementia: pharmacological and non-pharmacological interventions demonstrate small effects on heterogeneous scales].
Journal: Psychiatrische Praxis 20110701
Title: [Prescription differences of dementia drugs in urban and rural areas in Germany].
Journal: Psychiatrische Praxis 20110701
Title: Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study.
Journal: Current medical research and opinion 20110701
Title: Transdermal rivastigmine: management of cutaneous adverse events and review of the literature.
Journal: CNS drugs 20110701
Title: A 24-week, multicentre, open evaluation of the clinical effectiveness of the rivastigmine patch in patients with probable Alzheimer's disease.
Journal: International journal of clinical practice 20110701
Title: Rivastigmine associated hyponatremia in an older patient with Alzheimer's disease.
Journal: Journal of the American Geriatrics Society 20110701
Title: [Preparation of rivastigmine liposome and its pharmacokinetics in rats after intranasal administration].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20110701
Title: Rivastigmine transdermal patch: a review of its use in the management of dementia of the Alzheimer's type.
Journal: Drugs 20110618
Title: Evaluation of the convenience of changing the rivastigmine administration route in patients with Alzheimer disease.
Journal: Neurologia (Barcelona, Spain) 20110601
Title: Rivastigmine reverses aluminum-induced behavioral changes in rats.
Journal: European journal of pharmacology 20110601
Title: First case of symmetric drug-related intertriginous and flexural exanthema (sdrife) due to rivastigmine?
Journal: American journal of clinical dermatology 20110601
Title: Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models.
Journal: International journal of geriatric psychiatry 20110501
Title: Diagnosis of Alzheimer's disease patients with rapid cognitive decline in clinical practice: interest of the Deco questionnaire.
Journal: The journal of nutrition, health & aging 20110501
Title: Rivastigmine patches: fatal overdoses.
Journal: Prescrire international 20110501
Title: Design and evaluation of chitosan nanoparticles as novel drug carrier for the delivery of rivastigmine to treat Alzheimer's disease.
Journal: Therapeutic delivery 20110501
Title: Switching cholinesterase inhibitors in older adults with dementia.
Journal: International psychogeriatrics 20110401
Title: Dose effects associated with rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease.
Journal: International journal of clinical practice 20110401
Title: Efficacy of rivastigmine transdermal patch on activities of daily living: item responder analyses.
Journal: International journal of geriatric psychiatry 20110401
Title: [Delirium in the elderly].
Journal: Deutsche medizinische Wochenschrift (1946) 20110401
Title: Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account.
Journal: Prescrire international 20110401
Title: Cholinesterase inhibitor treatment in patients with delirium.
Journal: Lancet (London, England) 20110312
Title: Cholinesterase inhibitor treatment in patients with delirium.
Journal: Lancet (London, England) 20110312
Title: Cholinesterase inhibitor treatment in patients with delirium.
Journal: Lancet (London, England) 20110312
Title: Cholinesterase inhibitor treatment in patients with delirium.
Journal: Lancet (London, England) 20110312
Title: Development and validation of a HPLC method for quantification of rivastigmine in rat urine and identification of a novel metabolite in urine by LC-MS/MS.
Journal: Biomedical chromatography : BMC 20110301
Title: Cardio-vascular safety of acetyl cholinesterase inhibitors in patients suffering from Alzheimer's disease; factors that predict poor tolerability.
Journal: International journal of geriatric psychiatry 20110301
Title: Alzheimer's drug proves ineffective for delirium.
Journal: The Harvard mental health letter 20110301
Title: Acetylcholine and chronic vasculopathy in rat renal allografts.
Journal: Transplantation 20110215
Title: Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment.
Journal: The Gerontologist 20110201
Title: Impact of rivastigmine patch and capsules on activities of daily living in Alzheimer's disease.
Journal: American journal of Alzheimer's disease and other dementias 20110201
Title: Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions: Evidence is not satisfactory.
Journal: Deutsches Arzteblatt international 20110201
Title: Reversible and persistent decreases in cocaine self-administration after cholinesterase inhibition: different effects of donepezil and rivastigmine.
Journal: Behavioural pharmacology 20110201
Title: Long-term outcome and prediction models of activities of daily living in Alzheimer disease with cholinesterase inhibitor treatment.
Journal: Alzheimer disease and associated disorders 20110101
Title: Effects of body weight on tolerability of rivastigmine transdermal patch: a post-hoc analysis of a double-blind trial in patients with Alzheimer disease.
Journal: Alzheimer disease and associated disorders 20110101
Title: [Somatoform disorder or neurological syndrome? Complex mental and movement disorder and autonomic dysfunction in a 65-year-old patient - Case 1/2011].
Journal: Deutsche medizinische Wochenschrift (1946) 20110101
Title: Cutaneous reactions to transdermal therapeutic systems.
Journal: Dermatitis : contact, atopic, occupational, drug 20110101
Title: Rivastigmine lowers Aβ and increases sAPPα levels, which parallel elevated synaptic markers and metabolic activity in degenerating primary rat neurons.
Journal: PloS one 20110101
Title: Paraoxonase 1 gene polymorphisms do not influence the response to treatment in Alzheimer's disease.
Journal: Dementia and geriatric cognitive disorders 20110101
Title: Potential cardiotoxic reaction involving rivastigmine and beta-blockers: a case report and review of the literature.
Journal: Cardiovascular toxicology 20101201
Title: Efficacy of rivastigmine on executive function in patients with Parkinson's disease dementia.
Journal: CNS neuroscience & therapeutics 20101201
Title: Reviews: Effects of transdermal rivastigmine on ADAS-cog items in mild-to-moderate Alzheimer's disease.
Journal: American journal of Alzheimer's disease and other dementias 20101201
Title: Safety and efficacy of rivastigmine in adolescents with Down syndrome: long-term follow-up.
Journal: Journal of child and adolescent psychopharmacology 20101201
Title: Delirium treatment: an unmet challenge.
Journal: Lancet (London, England) 20101127
Title: Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.
Journal: Lancet (London, England) 20101127
Title: Use of antipsychotic drugs in patients with Alzheimer's disease treated with rivastigmine versus donepezil: a retrospective, parallel-cohort, hypothesis-generating study.
Journal: Drugs & aging 20101101
Title: Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20101001
Title: The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's disease.
Journal: Current medical research and opinion 20101001
Title: Cannabinoid and cholinergic systems interact during performance of a short-term memory task in the rat.
Journal: Learning & memory (Cold Spring Harbor, N.Y.) 20101001
Title: Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions.
Journal: Deutsches Arzteblatt international 20101001
Title: [Rivastigmine patch effective for 24 hours. Effective dose, good tolerance, reliable therapeutic effectiveness].
Journal: MMW Fortschritte der Medizin 20100916
Title: Drug treatment of Alzheimer's disease patients leads to expression changes in peripheral blood cells.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association 20100901
Title: Current treatments for patients with Alzheimer disease.
Journal: The Journal of the American Osteopathic Association 20100901
Title: Modern care for patients with Alzheimer disease: rationale for early intervention.
Journal: The Journal of the American Osteopathic Association 20100901
Title: Chemoenzymatic asymmetric total synthesis of (S)-Rivastigmine using omega-transaminases.
Journal: Chemical communications (Cambridge, England) 20100814
Title: Management of inappropriate sexual behaviors in dementia: a literature review.
Journal: International psychogeriatrics 20100801
Title: Rivastigmine in the treatment of delirium in older people: a pilot study.
Journal: International psychogeriatrics 20100801
Title: Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.
Journal: CNS neuroscience & therapeutics 20100801
Title: Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items.
Journal: American journal of Alzheimer's disease and other dementias 20100801
Title: Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer's disease.
Journal: Biomaterials 20100801
Title: Predictors of adherence among Alzheimer's disease patients receiving oral therapy.
Journal: Current medical research and opinion 20100801
Title: Discontinuation of cholinesterase inhibitor treatment and determinants thereof in the Netherlands: A retrospective cohort study.
Journal: Drugs & aging 20100801
Title: Maculopapular eruption to rivastigmine's transdermal patch application and successful oral desensitization.
Journal: Allergy 20100701
Title: Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review.
Journal: Pharmacological research 20100601
Title: Effects of oral rivastigmine on cognitive domains in mild-to-moderate Alzheimer's disease.
Journal: American journal of Alzheimer's disease and other dementias 20100601
Title: How do we treat people with dementia in Croatia.
Journal: Psychiatria Danubina 20100601
Title: [Oral galantamine versus rivastigmine transdermal patch: a descriptive study at a memory clinic in The Netherlands].
Journal: Tijdschrift voor gerontologie en geriatrie 20100601
Title: Study of rivastigmine for delirium in intensive care is stopped after deaths.
Journal: BMJ (Clinical research ed.) 20100528
Title: Chemoenzymatic synthesis of rivastigmine via dynamic kinetic resolution as a key step.
Journal: The Journal of organic chemistry 20100507
Title: Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease.
Journal: Journal of neurology, neurosurgery, and psychiatry 20100501
Title: Effects of rivastigmine on common symptomatology of Alzheimer's disease (EXPLORE).
Journal: Current medical research and opinion 20100501
Title: Anticholinesterase duration in the Australian veteran population.
Journal: The Australian and New Zealand journal of psychiatry 20100501
Title: Spectrophotometric and spectrodensitometric methods for the determination of rivastigmine hydrogen tartrate in presence of its degradation product.
Journal: Drug testing and analysis 20100501
Title: Identification and characterization of new impurities in rivastigmine.
Journal: Die Pharmazie 20100501
Title: [Variability and trends in dementia drug consumption in Castile-La Mancha (Spain). Estimated prevalence of Alzheimer's disease].
Journal: Neurologia (Barcelona, Spain) 20100501
Title: Agrypnia with nocturnal confusional behaviors in dementia with Lewy bodies: immediate efficacy of rivastigmine.
Journal: Movement disorders : official journal of the Movement Disorder Society 20100415
Title: Rivastigmine-induced REM sleep behavior disorder (RBD) in a 88-year-old man with Alzheimer's disease.
Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20100415
Title: Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32).
Journal: International journal of geriatric psychiatry 20100401
Title: A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease.
Journal: Acta neurologica Scandinavica 20100401
Title: Rivastigmine transdermal system for the treatment of mild to moderate Alzheimer's disease.
Journal: International journal of clinical practice 20100401
Title: Cholinesterase inhibitors and delirium after cardiac surgery.
Journal: Critical care medicine 20100401
Title: Transdermal rivastigmine for Alzheimer's disease: skin deep or scratching the surface?
Journal: International journal of clinical practice 20100401
Title: Treatment of apathy in Alzheimer's disease with transdermal rivastigmine: report of three cases.
Journal: Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20100301
Title: A novel effect of rivastigmine on pre-synaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer's disease.
Journal: Journal of neurochemistry 20100201
Title: A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis.
Journal: Current medical research and opinion 20100201
Title: Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study.
Journal: CNS drugs 20100201
Title: Rivastigmine transdermal patch skin tolerability: results of a 1-year clinical trial in patients with mild-to-moderate Alzheimer's disease.
Journal: Clinical drug investigation 20100101
Title: Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia.
Journal: Expert opinion on drug safety 20100101
Title: Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch.
Journal: CNS neuroscience & therapeutics 20100101
Title: Safety and tolerability of rivastigmine transdermal patch compared with rivastigmine capsules in patients switched from donepezil: data from three clinical trials.
Journal: International journal of clinical practice 20100101
Title: Improvement of cognitive dysfunction with high-dose rivastigmine.
Journal: Psychosomatics 20100101
Title: Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association 20100101
Title: Frontotemporal dementia and pharmacologic interventions.
Journal: The Journal of neuropsychiatry and clinical neurosciences 20100101
Title: Effects of rivastigmine in Alzheimer's disease patients with and without hallucinations.
Journal: Journal of Alzheimer's disease : JAD 20100101
Title: Investigation of liposome formulation effects on rivastigmine transport through human colonic adenocarcinoma cell line (CACO-2).
Journal: Die Pharmazie 20100101
Title: Lower Barthel Index scores predict less prescription of pharmacological therapy in elderly patients with Alzheimer disease.
Journal: Dementia and geriatric cognitive disorders 20100101
Title: Effects of rivastigmine transdermal patch and capsule on aspects of clinical global impression of change in Alzheimer's disease: a retrospective analysis.
Journal: Dementia and geriatric cognitive disorders 20100101
Title: Rivastigmine in the treatment of dementia associated with Parkinson's disease: effects on activities of daily living.
Journal: Dementia and geriatric cognitive disorders 20100101
Title: Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report.
Journal: BMC psychiatry 20100101
Title: Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a review of the literature.
Journal: BMC psychiatry 20100101
Title: Neurovascular coupling in Parkinson's disease patients: effects of dementia and acetylcholinesterase inhibitor treatment.
Journal: Journal of Alzheimer's disease : JAD 20100101
Title: [Rivastigmine in the treatment of dementia: from the symptomatic effect to neuroprotection].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101
Title: [Cholinergic therapy of Alzheimer's disease and its effect on health and quality of life of caregivers to the patients].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101
Title: An open-label pilot study of the use of rivastigmine to promote functional recovery in patients with unilateral spatial neglect due to first ischemic stroke.
Journal: Functional neurology 20100101
Title: [Efficacy and safety of rivastigmine (exelon) in the confusion syndrome in the acute phase of ischemic stroke].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101
Title: [Cholinesterase inhibitors for treating dementia. Review].
Journal: Vertex (Buenos Aires, Argentina) 20100101
Title: Phospholipase C beta 4 in the medial septum controls cholinergic theta oscillations and anxiety behaviors.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20091209
Title: Neurovascular coupling in Alzheimer patients: effect of acetylcholine-esterase inhibitors.
Journal: Neurobiology of aging 20091201
Title: International price comparisons of Alzheimer's drugs: a way to close the affordability gap.
Journal: International psychogeriatrics 20091201
Title: Effectiveness of donepezil, rivastigmine, and (+/-)huperzine A in counteracting the acute toxicity of organophosphorus nerve agents: comparison with galantamine.
Journal: The Journal of pharmacology and experimental therapeutics 20091201
Title: Peripheral cholinoceptor antagonist anisodamine counteracts cholinergic adverse effects and facilitates cognitive amelioration of rivastigmine.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20091201
Title: Rivastigmine for cognitive impairment after spontaneous subarachnoid haemorrhage: a pilot study.
Journal: Journal of clinical pharmacy and therapeutics 20091201
Title: Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system.
Journal: Journal of the American Geriatrics Society 20091101
Title: Hepatitis with cholestasis caused by rivastigmine transdermal patch.
Journal: The American journal of gastroenterology 20091101
Title: Alzheimer's disease: Seeing the signs early.
Journal: Journal of the American Academy of Nurse Practitioners 20091101
Title: Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
Journal: International psychogeriatrics 20091001
Title: Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
Journal: Bioorganic & medicinal chemistry 20090915
Title: Rivastigmine reverses habituation memory impairment observed in sepsis survivor rats.
Journal: Shock (Augusta, Ga.) 20090901
Title: Use of pralidoxime without atropine in rivastigmine (carbamate) toxicity.
Journal: Human & experimental toxicology 20090901
Title: [The possible value of diagnosing MCI-DLB and treatment options].
Journal: Tijdschrift voor gerontologie en geriatrie 20090901
Title: Chemoenzymatic synthesis of rivastigmine based on lipase-catalyzed processes.
Journal: The Journal of organic chemistry 20090807
Title: Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
Journal: European journal of pharmacology 20090801
Title: Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment.
Journal: Pharmacogenetics and genomics 20090801
Title: Rivastigmine in Parkinson's disease dementia.
Journal: Expert opinion on drug metabolism & toxicology 20090801
Title: Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment.
Journal: Acta pharmacologica Sinica 20090701
Title: Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia.
Journal: The neurologist 20090701
Title: Effects of gender on response to treatment with rivastigmine in mild cognitive impairment: A post hoc statistical modeling approach.
Journal: Gender medicine 20090701
Title: [Mental handicap].
Journal: Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 20090701
Title: Rational design of central selective acetylcholinesterase inhibitors by means of a 'bio-oxidisable prodrug' strategy.
Journal: Organic & biomolecular chemistry 20090621
Title: Novel carbamate cholinesterase inhibitors that release biologically active amines following enzyme inhibition.
Journal: Bioorganic & medicinal chemistry letters 20090615
Title: Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and Rivastigmine.
Journal: American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20090605
Title: [Rivastigmine in a case of autopsy proved frontotemporal dementia (Pick's disease)].
Journal: Revista de neurologia 20090601
Title: A randomized controlled trial of rivastigmine for chronic sequels of traumatic brain injury-what it showed and taught?
Journal: Brain injury 20090601
Title: Predicting time to nursing home placement based on activities of daily living scores--a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezil.
Journal: Journal of medical economics 20090601
Title: Drug-induced sialorrhoea and excessive saliva accumulation.
Journal: Prescrire international 20090601
Title: [Progressive supranucleair palsy: acetylcholineeserase-inhibitor a possible therapy?].
Journal: Tijdschrift voor gerontologie en geriatrie 20090601
Title: Treatment of Alzheimer's disease in the long-term-care setting.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20090515
Title: Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery--a randomized controlled trial.
Journal: Critical care medicine 20090501
Title: Cholinergic modulation of MEG resting-state oscillatory activity in Parkinson's disease related dementia.
Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 20090501
Title: Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review.
Journal: International journal of clinical practice 20090501
Title: Rivastigmine reduces tobacco craving in alcohol-dependent smokers.
Journal: Pharmacopsychiatry 20090501
Title: Rivastigmine for Alzheimer's disease.
Journal: The Cochrane database of systematic reviews 20090415
Title: Similar rivastigmine pharmacokinetics and pharmacodynamics in Japanese and white healthy participants following the application of novel rivastigmine patch.
Journal: Journal of clinical pharmacology 20090401
Title: [Treatment of degenerative dementia disorders--who should be treated?].
Journal: Ugeskrift for laeger 20090302
Title: Long-term rivastigmine treatment in a routine clinical setting.
Journal: Acta neurologica Scandinavica 20090301
Title: Acteylcholinesterase inhibitor rivastigmine enhances cellular defenses in neuronal and macrophage-like cell lines.
Journal: Translational research : the journal of laboratory and clinical medicine 20090301
Title: Effects of cholinesterase inhibition on brain white matter volume in Alzheimer's disease.
Journal: Neuroreport 20090218
Title: BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline.
Journal: Movement disorders : official journal of the Movement Disorder Society 20090215
Title: Top cited papers in International Psychogeriatrics: 1. Long-term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial.
Journal: International psychogeriatrics 20090201
Title: Simultaneous determination of galantamine, rivastigmine and NAP 226-90 in plasma by MEKC and its application in Alzheimer's disease.
Journal: Electrophoresis 20090201
Title: Long-term effects of rivastigmine capsules in patients with traumatic brain injury.
Journal: Brain injury 20090201
Title: Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.
Journal: Current Alzheimer research 20090201
Title: Adherence to cholinesterase inhibitors in patients with Alzheimer's disease.
Journal: Journal of the American Geriatrics Society 20090201
Title: Rivastigmine for dementia in people with Down syndrome.
Journal: The Cochrane database of systematic reviews 20090121
Title: Accommodation of physostigmine and its analogues by acetylcholinesterase is dominated by hydrophobic interactions.
Journal: The Biochemical journal 20090101
Title: Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine.
Journal: Psychopharmacology 20090101
Title: Improvement of spontaneous speech in early stage Alzheimer's with rivastigmine.
Journal: The journal of nutrition, health & aging 20090101
Title: [The role of rivastigmine (exelon) in the treatment of consequences of cranial-brain trauma].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101
Title: [Transdermal rivastigmine patch in outpatient services in Austria: a naturalistic study in 103 patients with Alzheimer dementia].
Journal: Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater 20090101
Title: Inhibitory potency of choline esterase inhibitors on acetylcholine release and choline esterase activity in fresh specimens of human and rat neocortex.
Journal: Journal of Alzheimer's disease : JAD 20090101
Title: Switching from donepezil tablets to rivastigmine transdermal patch in Alzheimer's disease.
Journal: American journal of Alzheimer's disease and other dementias 20090101
Title: Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice.
Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20090101
Title: Safety and tolerability of the rivastigmine patch: results of a 28-week open-label extension.
Journal: Alzheimer disease and associated disorders 20090101
Title: Persistence with cholinesterase inhibitor therapy for dementia: an observational administrative health database study.
Journal: Drugs & aging 20090101
Title: [Results of the open multicenter prospective study of safety and tolerability of rivastigmine (exelon) in different titration regimes in mild and moderate Alzheimer's disease].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101
Title: Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients?
Journal: Dementia and geriatric cognitive disorders 20090101
Title: Neurometabolic correlations of donepezil and rivastigmine in dementia patients: a different neuroprotective effect.
Journal: The Journal of neuropsychiatry and clinical neurosciences 20090101
Title: Safety/Tolerability and efficacy of rivastigmine in taiwanese patients with Alzheimer's disease: a prospective post-marketing surveillance study.
Journal: Clinical drug investigation 20090101
Title: Safety and tolerability of donepezil, rivastigmine and galantamine for patients with Alzheimer's disease: systematic review of the 'real-world' evidence.
Journal: Dementia and geriatric cognitive disorders 20090101
Title: Gender differences in the pharmacokinetics of rivastigmine in rats.
Journal: Arzneimittel-Forschung 20090101
Title: Predictors of long-term treatment effect of rivastigmine in Alzheimer's disease: a role for beta-amyloid plasma levels?
Journal: Neurologia i neurochirurgia polska 20090101
Title: Use of rivastigmine transdermal patch in the treatment of Alzheimer's disease.
Journal: Expert opinion on drug delivery 20081201
Title: Brain cholinergic impairment in liver failure.
Journal: Brain : a journal of neurology 20081101
Title: Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine.
Journal: Journal of neuroimmunology 20081015
Title: Effects of cholinesterase inhibitors on rat nicotinic receptor levels in vivo and in vitro.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20081001
Title: Pharmacological treatment in moderate-to-severe Alzheimer's disease.
Journal: Expert opinion on pharmacotherapy 20081001
Title: Evaluation of the cardiovascular and subjective effects of rivastigmine in combination with methamphetamine in methamphetamine-dependent human volunteers.
Journal: The international journal of neuropsychopharmacology 20080901
Title: Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study.
Journal: Current medical research and opinion 20080901
Title: [Alzheimer type dementia].
Journal: Revue de l'infirmiere 20080901
Title: Effects of rivastigmine on memory and cognition in multiple sclerosis.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20080901
Title: Drug utilization review of cholinesterase inhibitors in Quebec.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20080901
Title: [A transdermal patch of rivastigmine (Exelon)].
Journal: Revue medicale de Liege 20080901
Title: A study of rivastigmine liposomes for delivery into the brain through intranasal route.
Journal: Acta pharmaceutica (Zagreb, Croatia) 20080901
Title: Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients.
Journal: Movement disorders : official journal of the Movement Disorder Society 20080815
Title: Rivastigmine in Parkinson's disease dementia.
Journal: Expert review of neurotherapeutics 20080801
Title: Rivastigmine transdermal patch: role in the management of Alzheimer's disease.
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20080801
Title: Prevalence of cholinesterase inhibitors in subjects with dementia in Europe.
Journal: Pharmacoepidemiology and drug safety 20080701
Title: Rivastigmine effects on EEG spectra and three-dimensional LORETA functional imaging in Alzheimer's disease.
Journal: Psychopharmacology 20080601
Title: Complete atrioventricular block associated with rivastigmine therapy.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080601
Title: Miniaturized membrane sensors for the determination of rivastigmine hydrogen tartrate.
Journal: Chemical & pharmaceutical bulletin 20080601
Title: Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease.
Journal: Journal of managed care pharmacy : JMCP 20080601
Title: [A comparative study of the effectiveness and tolerability of a procedure involving slow dose-escalation of rivastigmine in patients with mild or moderate Alzheimer-type dementia: the SCALEX study].
Journal: Revista de neurologia 20080501
Title: Dementia medications in palliative care #174.
Journal: Journal of palliative medicine 20080501
Title: [Treatment of Alzheimer's disease: status quo and future considerations].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20080501
Title: Parkinson's disease in the elderly.
Journal: Medicine and health, Rhode Island 20080501
Title: Diagnosis and treatment of dementia with Lewy bodies.
Journal: JAAPA : official journal of the American Academy of Physician Assistants 20080501
Title: AAFP and ACP release guideline on dementia treatment.
Journal: American family physician 20080415
Title: In situ-forming oleogel implant for rivastigmine delivery.
Journal: Pharmaceutical research 20080401
Title: Facile synthesis of new carbon-11 labeled conformationally restricted rivastigmine analogues as potential PET agents for imaging AChE and BChE enzymes.
Journal: Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20080401
Title: The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.
Journal: Pharmacology, biochemistry, and behavior 20080401
Title: A rivastigmine patch for dementia.
Journal: The Medical letter on drugs and therapeutics 20080324
Title: Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
Journal: Brain research 20080320
Title: A nanoparticulate drug-delivery system for rivastigmine: physico-chemical and in vitro biological characterization.
Journal: Macromolecular bioscience 20080310
Title: Summaries for patients. Drug treatment for patients with dementia: American College of Physicians and American Academy of Family Physicians recommendations.
Journal: Annals of internal medicine 20080304
Title: Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.
Journal: Annals of internal medicine 20080304
Title: Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.
Journal: Annals of internal medicine 20080304
Title: Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.
Journal: Pharmacotherapy 20080301
Title: Microcalorimetric study of the inhibition of butyrylcholinesterase by carbamates.
Journal: Analytical biochemistry 20080215
Title: Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
Journal: International journal of geriatric psychiatry 20080201
Title: A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease.
Journal: International journal of geriatric psychiatry 20080201
Title: Acetylcholinesterase inhibitors in assisted living: patterns of use and association with retention.
Journal: International journal of geriatric psychiatry 20080201
Title: Neurological signs in relation to type of cerebrovascular disease in vascular dementia.
Journal: Stroke 20080201
Title: Pharmacokinetics and bioavailability of the novel rivastigmine transdermal patch versus rivastigmine oral solution in healthy elderly subjects.
Journal: Journal of clinical pharmacology 20080201
Title: Pharmacologic management of Alzheimer disease.
Journal: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses 20080201
Title: [Cholinesterase inhibitors in the treatment of dementia--are they useful in clinical practice?].
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20080131
Title: Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients.
Journal: Clinical pharmacology and therapeutics 20080101
Title: [Therapy of cognitive deficits in schizophrenia with acetylcholinesterase inhibitors. A systematic overview].
Journal: Der Nervenarzt 20080101
Title: Rivastigmine in Wernicke-Korsakoff's syndrome: five patients with rivastigmine showed no more improvement than five patients without rivastigmine.
Journal: Alcohol and alcoholism (Oxford, Oxfordshire) 20080101
Title: Identification of responders to rivastigmine: a prospective cohort study.
Journal: Dementia and geriatric cognitive disorders 20080101
Title: A systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurological disorders.
Journal: Current medical research and opinion 20080101
Title: Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia: a retrospective analysis of a double-blind trial and an open-label extension.
Journal: Drug safety 20080101
Title: Different responses to rivastigmine in subcortical vascular dementia and multi-infarct dementia.
Journal: American journal of Alzheimer's disease and other dementias 20080101
Title: Estimated pre-morbid IQ effects on cognitive and functional outcomes in Alzheimer disease: a longitudinal study in a treated cohort.
Journal: BMC psychiatry 20080101
Title: Steady-state pharmacokinetics of rivastigmine in patients with mild to moderate Alzheimer's disease not affected by co-administration of memantine: an open-label, crossover, single-centre study.
Journal: Clinical drug investigation 20080101
Title: Impact of rivastigmine on caregiver burden associated with Alzheimer's disease in both informal care and nursing home settings.
Journal: Drugs & aging 20080101
Title: Fluorimetric determination of rivastigmine in rat plasma by a reverse phase--high performance liquid chromatographic method. Application to a pharmacokinetic study.
Journal: Arzneimittel-Forschung 20080101
Title: Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.
Journal: Clinical interventions in aging 20080101
Title: A pilot study of rivastigmine in the treatment of delirium after stroke: a safe alternative.
Journal: BMC neurology 20080101
Title: [The treatment of Alzheimer's disease in patients with comorbid somatic pathology].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101
Title: Student pharmacists: don't forget the product labeling.
Journal: Journal of the American Pharmacists Association : JAPhA 20080101
Title: A new way of data interpretation for cognition tests in rats used to characterise six choline esterase inhibitors with heterocyclic nitrogen bridgehead structure. Application in Alzheimer therapy.
Journal: Arzneimittel-Forschung 20080101
Title: Discontinuing Alzheimer's disease drug therapy: why, when, and how.
Journal: Director (Cincinnati, Ohio) 20080101
Title: Focusing effect of acetylcholine on neuroplasticity in the human motor cortex.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20071226
Title: Rivastigmine exposure provided by a transdermal patch versus capsules.
Journal: Current medical research and opinion 20071201
Title: Rivastigmine-induced dystonia.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20071201
Title: Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
Journal: Psychiatry and clinical neurosciences 20071201
Title: [Rivastigmine against dementia in Parkinson disease?].
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20071115
Title: A rivastigmine patch for the treatment of Alzheimer's disease and Parkinson's disease dementia.
Journal: Expert review of neurotherapeutics 20071101
Title: N1phenethyl-norcymserine, a selective butyrylcholinesterase inhibitor, increases acetylcholine release in rat cerebral cortex: a comparison with donepezil and rivastigmine.
Journal: European journal of pharmacology 20071031
Title: Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease.
Journal: Journal of neurology, neurosurgery, and psychiatry 20071001
Title: Subthreshold depression in patients with Parkinson's disease and dementia--clinical and demographic correlates.
Journal: International journal of geriatric psychiatry 20071001
Title: [Lewy body dementia and Parkinson disease dementia].
Journal: Presse medicale (Paris, France : 1983) 20071001
Title: Patient and caregiver outcomes after 6 +/- 1.5-months of rivastigmine therapy for mild-to-moderate Alzheimer's disease: the Belgian FExT study.
Journal: Current medical research and opinion 20071001
Title: Evaluation of centrally acting cholinesterase inhibitor exposures in adults.
Journal: The Annals of pharmacotherapy 20071001
Title: Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial.
Journal: Journal of clinical psychopharmacology 20071001
Title: Cholinergic balance in dementia with Lewy bodies: reversible worsening of Parkinsonism at rivastigmine dosage modulation.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20071001
Title: Diagnosis and management of vascular cognitive impairment.
Journal: Current atherosclerosis reports 20071001
Title: [Are anti-dementia drugs worthwhile?].
Journal: MMW Fortschritte der Medizin 20070913
Title: Cholinesterase inhibitors in dementia with Lewy bodies: a comparative analysis.
Journal: International journal of geriatric psychiatry 20070901
Title: Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
Journal: The Lancet. Neurology 20070901
Title: NICE judgement leaves behind a nasty taste.
Journal: Nursing older people 20070901
Title: Pharmacokinetic rationale for the rivastigmine patch.
Journal: Neurology 20070724
Title: IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease.
Journal: Neurology 20070724
Title: Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease.
Journal: Neurology 20070724
Title: Impairment of nonverbal recognition in Alzheimer disease: a PET O-15 study.
Journal: Neurology 20070703
Title: Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences.
Journal: Journal of Alzheimer's disease : JAD 20070701
Title: A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the estimation of rivastigmine in human plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070601
Title: The kinetics of inhibition of human acetylcholinesterase and butyrylcholinesterase by two series of novel carbamates.
Journal: Molecular pharmacology 20070601
Title: Potential ethnic modifiers in the assessment and treatment of Alzheimer's disease: challenges for the future.
Journal: International psychogeriatrics 20070601
Title: EXACT: rivastigmine improves the high prevalence of attention deficits and mood and behaviour symptoms in Alzheimer's disease.
Journal: International journal of clinical practice 20070601
Title: MCI treatment trials: failure or not?
Journal: The Lancet. Neurology 20070601
Title: Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.
Journal: The Lancet. Neurology 20070601
Title: [Cholinesterase inhibitors and Alzheimer's disease: meta-analysis of the verification of effectiveness, origin and bias of results in published studies].
Journal: Deutsche medizinische Wochenschrift (1946) 20070601
Title: [Rivastigmine solution prescribing habits in patients with Alzheimer-type dementia in Spain (RIVASOL study)].
Journal: Revista de neurologia 20070601
Title: Rivastigmine tartrate with a focus on dementia associated with Parkinson's disease.
Journal: Drugs of today (Barcelona, Spain : 1998) 20070601
Title: [Acetylcholinesterase inhibitors for dementia--an update].
Journal: MMW Fortschritte der Medizin 20070521
Title: Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
Journal: Neurology 20070515
Title: Effects of rivastigmine on cognitive function in patients with traumatic brain injury.
Journal: Neurology 20070515
Title: Identification of responders and reactive domains to rivastigmine in Alzheimer's disease.
Journal: Pharmacoepidemiology and drug safety 20070501
Title: Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.
Journal: Psychopharmacology 20070501
Title: A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule.
Journal: International journal of geriatric psychiatry 20070501
Title: Effect of anti-dementia drugs on LPS induced neuroinflammation in mice.
Journal: Life sciences 20070501
Title: Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease.
Journal: International journal of geriatric psychiatry 20070501
Title: [Hallucinations associated to treatment with rivastigmine in two patients with diffuse Lewy body disease].
Journal: Revista de neurologia 20070501
Title: Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease.
Journal: Journal of the American Geriatrics Society 20070501
Title: Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.
Journal: International journal of geriatric psychiatry 20070401
Title: Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study.
Journal: International journal of geriatric psychiatry 20070401
Title: Pharmacokinetics of a rivastigmine transdermal patch formulation in healthy volunteers: relative effects of body site application.
Journal: Journal of clinical pharmacology 20070401
Title: Rivastigmine and Parkinson dementia complex.
Journal: Expert opinion on pharmacotherapy 20070401
Title: Modulation of human motor cortex excitability by the cholinesterase inhibitor rivastigmine.
Journal: Neuroscience letters 20070319
Title: The application of evidence-based principles of care in older persons (issue 5): Alzheimer's disease.
Journal: Journal of the American Medical Directors Association 20070301
Title: Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits.
Journal: Current medical research and opinion 20070301
Title: Rivastigmine in the treatment of Alzheimer's disease: an update.
Journal: Clinical interventions in aging 20070301
Title: [Synthesis of S-(+)-rivastigmine hydrogentartrate].
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20070201
Title: Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study.
Journal: Archives of gerontology and geriatrics 20070101
Title: Strategies to improve tolerability of rivastigmine: a case series.
Journal: Current medical research and opinion 20070101
Title: Two years' follow-up of rivastigmine treatment in Huntington disease.
Journal: Clinical neuropharmacology 20070101
Title: Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl).
Journal: Archives of gerontology and geriatrics 20070101
Title: Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
Journal: Dementia and geriatric cognitive disorders 20070101
Title: Rivastigmine in Parkinson's disease dementia: profile report.
Journal: Drugs & aging 20070101
Title: Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study.
Journal: American journal of Alzheimer's disease and other dementias 20070101
Title: [Transdermal drugs in neurology].
Journal: Neurologia (Barcelona, Spain) 20070101
Title: Parkinson's disease-related visual hallucinations unresponsive to atypical antipsychotics treated with cholinesterase inhibitors: a case series.
Journal: Neurologia i neurochirurgia polska 20070101
Title: Domperidone is effective in the prevention of rivastigmine-related gastrointestinal disturbances.
Journal: Functional neurology 20070101
Title: Colchicines-induced neurotoxicity as an animal model of sporadic dementia of Alzheimer's type.
Journal: Pharmacological reports : PR 20070101
Title: Effect of rivastigmine on regional cerebral blood flow in Alzheimer's disease.
Journal: Advances in therapy 20070101
Title: Comparing treatment effects in a clinical sample of patients with probable Alzheimer's disease treated with two different cholinesterase inhibitors.
Journal: Acta bio-medica : Atenei Parmensis 20070101
Title: Plasma Abeta levels as predictors of response to rivastigmine treatment in Alzheimer's disease.
Journal: Acta neurobiologiae experimentalis 20070101
Title: Modelling disease progression in Alzheimer's disease: a review of modelling methods used for cost-effectiveness analysis.
Journal: PharmacoEconomics 20070101
Title: Rivastigmine transdermal patch: in the treatment of dementia of the Alzheimer's type.
Journal: CNS drugs 20070101
Title: Drug interactions with cholinesterase inhibitors: an analysis of the French pharmacovigilance database and a comparison of two national drug formularies (Vidal, British National Formulary).
Journal: Drug safety 20070101
Title: Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment.
Journal: Current medicinal chemistry 20070101
Title: Neuropsychological rehabilitation in mild and moderate Alzheimer's disease patients.
Journal: Behavioural neurology 20070101
Title: The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor.
Journal: British journal of pharmacology 20061201
Title: [Diagnosis and clinical therapy for Parkinson's disease].
Journal: Der Nervenarzt 20061201
Title: Safety and efficacy of rivastigmine in adolescents with Down syndrome: a preliminary 20-week, open-label study.
Journal: Journal of child and adolescent psychopharmacology 20061201
Title: 6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20061115
Title: Brain perfusion effects of cholinesterase inhibitors in Parkinson's disease with dementia.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20061101
Title: Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.
Journal: Movement disorders : official journal of the Movement Disorder Society 20061101
Title: Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease.
Journal: Pharmacogenetics and genomics 20061101
Title: A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: the EXTEND Study.
Journal: Current medical research and opinion 20061101
Title: Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.
Journal: Journal of psychiatry & neuroscience : JPN 20061101
Title: [Medical treatment of Alzheimer's disease].
Journal: Ugeskrift for laeger 20061002
Title: Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia.
Journal: Movement disorders : official journal of the Movement Disorder Society 20061001
Title: [Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine].
Journal: Revista de neurologia 20061001
Title: Use of antidementia agents in vascular dementia: beyond Alzheimer disease.
Journal: Mayo Clinic proceedings 20061001
Title: Unsubstantiated superiority claims for rivastigmine tartrate.
Journal: The Journal of the American Osteopathic Association 20061001
Title: Effects of rivastigmine on cognitive function in patients with traumatic brain injury.
Journal: Neurology 20060912
Title: Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats.
Journal: Acta pharmacologica Sinica 20060901
Title: Do caregivers' experiences correspond with the concerns raised in the literature? Ethical issues relating to anti-dementia drugs.
Journal: International journal of geriatric psychiatry 20060901
Title: Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease.
Journal: Journal of neurology 20060901
Title: [Advances in Alzheimer's disease treatment].
Journal: La Revue de medecine interne 20060801
Title: [Cholinesterase inhibitor therapy in long term care settings].
Journal: La Revue de medecine interne 20060801
Title: Alzheimer's disease.
Journal: Lancet (London, England) 20060729
Title: Are cholinergic enhancers beneficial for memory in schizophrenia? An event-related potentials (ERPs) study of rivastigmine add-on therapy in a crossover trial.
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20060701
Title: Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation.
Journal: Schizophrenia research 20060701
Title: Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20060701
Title: [Rivastigmine as adjunctive therapy in the therapeutic dilemma for the treatment of hallucinations due to Parkinson disease].
Journal: Tijdschrift voor gerontologie en geriatrie 20060701
Title: Antipsychotic drug use among nursing home residents taking rivastigmine.
Journal: Journal of the American Medical Directors Association 20060601
Title: Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias.
Journal: International journal of clinical practice 20060601
Title: Treatment effects of rivastigmine on cognition, performance of daily living activities and behaviour in Alzheimer's disease in an outpatient geriatric setting.
Journal: International journal of clinical practice 20060601
Title: Patterns of cholinesterase-inhibitor use in the nursing home setting: a retrospective analysis.
Journal: The American journal of geriatric pharmacotherapy 20060601
Title: Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study.
Journal: Movement disorders : official journal of the Movement Disorder Society 20060401
Title: Clinical trials in mild cognitive impairment: lessons for the future.
Journal: Journal of neurology, neurosurgery, and psychiatry 20060401
Title: Pharmacological manipulation of the vasoconstrictive effects of amyloid-beta peptides by donepezil and rivastigmine.
Journal: Current Alzheimer research 20060401
Title: Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings.
Journal: Journal of geriatric psychiatry and neurology 20060301
Title: Longitudinal observational studies to study the efficacy-effectiveness gap in drug therapy: application to mild and moderate dementia.
Journal: The Nursing clinics of North America 20060301
Title: Appeals system and its outcomes in national health insurance in Taiwan.
Journal: The Annals of pharmacotherapy 20060301
Title: Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.
Journal: Current medical research and opinion 20060301
Title: Serotonin depletion results in a decrease of the neuronal activation caused by rivastigmine in the rat hippocampus.
Journal: Brain research 20060216
Title: Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer's disease.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20060201
Title: Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmission.
Journal: Mechanisms of ageing and development 20060201
Title: Quetiapine and rivastigmine for agitation in Alzheimer's disease.
Journal: Current psychiatry reports 20060201
Title: Cholinesterase inhibitors for Parkinson's disease dementia.
Journal: The Cochrane database of systematic reviews 20060125
Title: Cholinesterase inhibitors for Alzheimer's disease.
Journal: The Cochrane database of systematic reviews 20060125
Title: Neural correlates of adjunctive rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind fMRI study.
Journal: NeuroImage 20060115
Title: A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease.
Journal: International journal of geriatric psychiatry 20060101
Title: Alarming arbitrariness in EU prescription and reimbursement criteria for anti-dementia drugs.
Journal: International journal of geriatric psychiatry 20060101
Title: Case of the month: rivastigmine (Exelon) toxicity with evidence of respiratory depression.
Journal: Emergency medicine journal : EMJ 20060101
Title: Circadian cholinergic rhythms: implications for cholinesterase inhibitor therapy.
Journal: Dementia and geriatric cognitive disorders 20060101
Title: Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology.
Journal: Current medical research and opinion 20060101
Title: Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment.
Journal: International journal of clinical practice 20060101
Title: The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.
Journal: Health technology assessment (Winchester, England) 20060101
Title: Antipsychotic drug use among nursing home residents taking rivastigmine.
Journal: Journal of the American Medical Directors Association 20060101
Title: Economic evaluation of rivastigmine in patients with Parkinson's disease dementia.
Journal: PharmacoEconomics 20060101
Title: Transdermal rivastigmine treatment does not worsen impaired performance of complex motions in patients with Alzheimer's disease.
Journal: Pharmacopsychiatry 20060101
Title: QEEG monitoring of Alzheimer's disease treatment: a preliminary report of three case studies.
Journal: Clinical EEG and neuroscience 20060101
Title: A pilot study evaluating the efficacy and safety of rivastigmine in patients with mixed dementia.
Journal: Drugs & aging 20060101
Title: Current and emerging pharmacological treatment options for dementia.
Journal: Behavioural neurology 20060101
Title: Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease.
Journal: Alzheimer disease and associated disorders 20060101
Title: Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease.
Journal: Drugs & aging 20060101
Title: Rivastigmine: in Parkinson's disease dementia.
Journal: CNS drugs 20060101
Title: [Pharmacotherapy for Alzheimer's disease].
Journal: Tijdschrift voor psychiatrie 20060101
Title: Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment.
Journal: The Journal of international medical research 20060101
Title: Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.
Journal: CNS drugs 20060101
Title: A simple and sensitive assay for the quantitative analysis of rivastigmine and its metabolite NAP 226-90 in human EDTA plasma using coupled liquid chromatography and tandem mass spectrometry.
Journal: Rapid communications in mass spectrometry : RCM 20060101
Title: Determination of therapeutics with growth-hormone secretagogue activity in human urine for doping control purposes.
Journal: Rapid communications in mass spectrometry : RCM 20060101
Title: Initiation of acetylcholinesterase inhibitors and complications of chronic airways disorders in elderly patients.
Journal: Drug safety 20060101
Title: Realistic expectations for treatment success in Alzheimer's disease.
Journal: The journal of nutrition, health & aging 20060101
Title: [Pharmacological approaches to the therapy of Alzheimer's disease].
Journal: Vestnik Rossiiskoi akademii meditsinskikh nauk 20060101
Title: Alzheimer disease and its management: a review.
Journal: American journal of therapeutics 20060101
Title: Relationship between the efficacy of rivastigmine and apolipoprotein E (epsilon4) in patients with mild to moderately severe Alzheimer disease.
Journal: Alzheimer disease and associated disorders 20060101
Title: First treatment for dementia of Parkinson's disease.
Journal: FDA consumer 20060101
Title: Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
Journal: The Journal of pharmacology and experimental therapeutics 20051201
Title: Discontinuation of rivastigmine in routine clinical practice.
Journal: International journal of geriatric psychiatry 20051201
Title: Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study.
Journal: Clinical rehabilitation 20051201
Title: Dementia.
Journal: Clinical evidence 20051201
Title: Benefits of rivastigmine on attention in dementia associated with Parkinson disease.
Journal: Neurology 20051122
Title: Behavioral and neuropsychiatric outcomes in Alzheimer's disease.
Journal: CNS spectrums 20051101
Title: Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer's disease.
Journal: Current medical research and opinion 20051101
Title: Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
Journal: Brain research 20051026
Title: The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats.
Journal: British journal of pharmacology 20051001
Title: Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease.
Journal: Current medical research and opinion 20051001
Title: Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects.
Journal: Psychopharmacology 20050901
Title: Rivastigmine for Alzheimer's disease.
Journal: Expert review of neurotherapeutics 20050901
Title: UK government guidance on Alzheimer's drugs postponed.
Journal: Drug discovery today 20050901
Title: Efficacy of rivastigmine on activities of daily living in Sri Lankan patients with Alzheimer disease and on improving caregiver burden: a prospective study.
Journal: The Ceylon medical journal 20050901
Title: Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a 26-week, multicenter, open-label study.
Journal: The American journal of geriatric pharmacotherapy 20050901
Title: Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.
Journal: BMJ (Clinical research ed.) 20050806
Title: One-year treatment of Alzheimer's disease with acetylcholinesterase inhibitors: improvement on ADAS-cog and TMT A, no change or worsening on other tests.
Journal: Human psychopharmacology 20050801
Title: Effects of rivastigmine on sustained attention in schizophrenia: an FMRI study.
Journal: Journal of clinical psychopharmacology 20050801
Title: Neurophysiological predictors of long term response to AChE inhibitors in AD patients.
Journal: Journal of neurology, neurosurgery, and psychiatry 20050801
Title: Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
Journal: Current medical research and opinion 20050801
Title: Pesticide-like poisoning from a prescription drug.
Journal: The New England journal of medicine 20050721
Title: Enantioselective separation of rivastigmine by capillary electrophoresis with cyclodextrines.
Journal: Journal of chromatography. A 20050715
Title: A cohort study of effectiveness of acetylcholinesterase inhibitors in Alzheimer's disease.
Journal: European journal of clinical pharmacology 20050701
Title: Cognitive performance in patients with Alzheimer's disease receiving cholinesterase inhibitors for up to 5 years.
Journal: International journal of clinical practice 20050701
Title: Cholinesterase inhibitors for treatment of dementia associated with Parkinson's disease.
Journal: Journal of neurology, neurosurgery, and psychiatry 20050701
Title: Rivastigmine for dementia associated with Parkinson's disease.
Journal: Current neurology and neuroscience reports 20050701
Title: [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
Journal: Tijdschrift voor gerontologie en geriatrie 20050701
Title: Treatment persistency with rivastigmine and donepezil in a large state medicaid program.
Journal: Journal of the American Geriatrics Society 20050701
Title: A validated chiral liquid chromatographic method for the enantiomeric separation of Rivastigmine hydrogen tartarate, a cholinesterase inhibitor.
Journal: Journal of pharmaceutical and biomedical analysis 20050615
Title: Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.
Journal: Psychopharmacology 20050601
Title: A study paradigm allowing comparison of multiple high-resolution rCBV-maps for the examination of drug effects.
Journal: NMR in biomedicine 20050601
Title: [Changing the anticholinesterase in Alzheimer's disease].
Journal: Revista de neurologia 20050601
Title: Acetylcholinesterase inhibitors reduce brain and blood interleukin-1beta production.
Journal: Annals of neurology 20050501
Title: Rivastigmine in the treatment of dementia in Alzheimer's disease in adults with Down syndrome.
Journal: International journal of geriatric psychiatry 20050501
Title: Rivastigmine for subcortical vascular dementia.
Journal: Expert review of neurotherapeutics 20050501
Title: Rivastigmine for vascular cognitive impairment.
Journal: The Cochrane database of systematic reviews 20050418
Title: Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.
Journal: BMJ (Clinical research ed.) 20050416
Title: Drugs for Alzheimer's disease and related dementias.
Journal: BMJ (Clinical research ed.) 20050416
Title: Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settings.
Journal: Journal of managed care pharmacy : JMCP 20050401
Title: Cognitive performance in Alzheimer's disease patients receiving rivastigmine for up to 5 years.
Journal: International journal of clinical practice 20050401
Title: Rivastigmine for dementia associated with Parkinson's disease.
Journal: The New England journal of medicine 20050331
Title: NICE proposes to withdraw Alzheimer's drugs from NHS.
Journal: BMJ (Clinical research ed.) 20050305
Title: Evidence for cholinesterase-inhibitor therapy for dementia associated with Parkinson's disease.
Journal: The Lancet. Neurology 20050301
Title: Successfully switching acetylcholinesterase inhibitor therapy in probable Lewy body dementia.
Journal: Journal of psychopharmacology (Oxford, England) 20050301
Title: Cholinesterase inhibitors in the treatment of dementia.
Journal: The Journal of the American Osteopathic Association 20050301
Title: Effects of rivastigmine in a case of residual schizophrenia.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050301
Title: Pharmacologic treatment options in Alzheimer's disease: optimizing disease management.
Journal: Journal of the American Academy of Nurse Practitioners 20050301
Title: Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
Journal: European journal of pharmacology 20050221
Title: Seizures associated with memantine use.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050215
Title: A stability indicating LC method for rivastigmine hydrogen tartrate.
Journal: Journal of pharmaceutical and biomedical analysis 20050207
Title: Rivastigmine as a modulator of the neuronal glutamate transporter rEAAC1 mRNA expression.
Journal: Dementia and geriatric cognitive disorders 20050101
Title: A 12-month study of the efficacy of rivastigmine in patients with advanced moderate Alzheimer's disease.
Journal: Dementia and geriatric cognitive disorders 20050101
Title: Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients.
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20050101
Title: Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients.
Journal: Dementia and geriatric cognitive disorders 20050101
Title: Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years.
Journal: BMC geriatrics 20050101
Title: Differential efficacy of treatment with acetylcholinesterase inhibitors in patients with mild and moderate Alzheimer's disease over a 6-month period.
Journal: Dementia and geriatric cognitive disorders 20050101
Title: Dementia treatment update.
Journal: Geriatric nursing (New York, N.Y.) 20050101
Title: Heterocyclic inhibitors of AChE acylation and peripheral sites.
Journal: Farmaco (Societa chimica italiana : 1989) 20050101
Title: [ApoE genotype and efficacy of neurotrophic and cholinergic therapy in Alzheimer's disease].
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20050101
Title: The use of the occupational disruptiveness scale of the neuropsychiatric inventory-nursing home version to measure the impact of rivastigmine on the disruptive behavior of nursing home residents with Alzheimer's disease.
Journal: Journal of the American Medical Directors Association 20050101
Title: The impact of acetylcholinergic medications on Alzheimer's disease-related behavioral disorders in nursing home patients: what is the real impact?
Journal: Journal of the American Medical Directors Association 20050101
Title: Drug persistency of two cholinesterase inhibitors: rivastigmine versus donepezil in elderly patients with Alzheimer's disease.
Journal: Drugs & aging 20050101
Title: Efficacy of rivastigmine in Alzheimer's disease patients with rapid disease progression: results of a meta-analysis.
Journal: Dementia and geriatric cognitive disorders 20050101
Title: Drug therapy of dementia in elderly patients. A review.
Journal: Nordic journal of psychiatry 20050101
Title: The potential value of negative studies.
Journal: Journal of the American Medical Directors Association 20050101
Title: Short-term treatment with rivastigmine and plasma levels of Abeta peptides in Alzheimer's disease.
Journal: Folia neuropathologica 20050101
Title: Poisoning with rivastigmine.
Journal: Clinical toxicology (Philadelphia, Pa.) 20050101
Title: [Use of acetylcholinesterase inhibitors and memantine in Alzheimer-type dementia].
Journal: Revista espanola de salud publica 20050101
Title: Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease.
Journal: Neurology 20041228
Title: Rivastigmine for dementia associated with Parkinson's disease.
Journal: The New England journal of medicine 20041209
Title: Parkinson's disease dementia--a first step?
Journal: The New England journal of medicine 20041209
Title: [Dementia-current knowledge and significance for ENT specialists].
Journal: HNO 20041201
Title: Effects of rivastigmine on motor and cognitive impairment in Huntington's disease.
Journal: Movement disorders : official journal of the Movement Disorder Society 20041201
Title: Dementia.
Journal: Clinical evidence 20041201
Title: [Clozapine for the treatment of psychosis in 3 elderly patients with Parkinson's disease].
Journal: Nederlands tijdschrift voor geneeskunde 20041127
Title: Impact of APOE in mild cognitive impairment.
Journal: Neurology 20041123
Title: Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
Journal: Journal of medicinal chemistry 20041118
Title: Treatment of vascular dementia--evidence from clinical trials with cholinesterase inhibitors.
Journal: Journal of the neurological sciences 20041115
Title: [Are there innovations in the treatment of Parkinson's disease?].
Journal: Praxis 20041103
Title: Efficacy of acetylcholinesterase inhibitors in frontotemporal dementia.
Journal: The Annals of pharmacotherapy 20041101
Title: Rivastigmine augmentation in the management of chronic schizophrenia with comorbid dementia: an open-label study investigating effects on cognition, behaviour and activities of daily living.
Journal: International clinical psychopharmacology 20041101
Title: Switching from donepezil or rivastigmine to galantamine in clinical practice.
Journal: Journal of the American Geriatrics Society 20041101
Title: An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting.
Journal: Current medical research and opinion 20041101
Title: Fluctuations in cognition and alertness in Parkinson's disease and dementia.
Journal: Neurology 20041026
Title: Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
Journal: European journal of pharmacology 20041025
Title: [Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine].
Journal: Nederlands tijdschrift voor geneeskunde 20041023
Title: Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
Journal: Current medical research and opinion 20041001
Title: Evidence-based pharmacotherapy of Alzheimer's disease.
Journal: The international journal of neuropsychopharmacology 20040901
Title: Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain.
Journal: Neuropharmacology 20040901
Title: Adding rivastigmine to antipsychotics in the treatment of a chronic delirium.
Journal: Age and ageing 20040901
Title: The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.
Journal: Expert opinion on drug safety 20040901
Title: [Drug-cholinesterase-inhibitors persistence patterns in treated patients with dementia of Alzheimer type: retrospective comparative analysis of donepezil, rivastigmine and galantamine].
Journal: Revista de neurologia 20040801
Title: [Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine].
Journal: Nederlands tijdschrift voor geneeskunde 20040724
Title: Headspace solid-phase microextraction and capillary gas chromatographic-mass spectrometric determination of rivastigmine in canine plasma samples.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040705
Title: A case study in the treatment of dementia with Lewy bodies.
Journal: Acta psychiatrica Scandinavica 20040701
Title: Understanding the latest advances in pharmacologic interventions for Alzheimer's disease.
Journal: CNS spectrums 20040701
Title: Delirium in elderly hospitalised patients: protective effects of chronic rivastigmine usage.
Journal: International journal of geriatric psychiatry 20040701
Title: Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease.
Journal: Clinical therapeutics 20040701
Title: Absorption of rivastigmine from different regions of the gastrointestinal tract in humans.
Journal: Journal of clinical pharmacology 20040601
Title: Rivastigmine in vascular dementia.
Journal: Expert opinion on pharmacotherapy 20040601
Title: Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
Journal: International journal of geriatric psychiatry 20040601
Title: Dementia.
Journal: Clinical evidence 20040601
Title: Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats.
Journal: Neuroscience letters 20040506
Title: Effect of treatment with the cholinesterase inhibitor rivastigmine on vesicular acetylcholine transporter and choline acetyltransferase in rat brain.
Journal: Clinical and experimental hypertension (New York, N.Y. : 1993) 20040501
Title: Behavioral symptoms in mild cognitive impairment.
Journal: Neurology 20040413
Title: Emerging therapies for vascular dementia and vascular cognitive impairment.
Journal: Stroke 20040401
Title: Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease.
Journal: Journal of neurology, neurosurgery, and psychiatry 20040401
Title: Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients.
Journal: European journal of neurology 20040401
Title: A simple, rapid and sensitive method for simultaneous determination of rivastigmine and its major metabolite NAP 226-90 in rat brain and plasma by reversed-phase liquid chromatography coupled to electrospray ionization mass spectrometry.
Journal: Biomedical chromatography : BMC 20040401
Title: Rivastigmine superior to aspirin plus nimodipine in subcortical vascular dementia: an open, 16-month, comparative study.
Journal: International journal of clinical practice 20040401
Title: Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients.
Journal: Journal of neurochemistry 20040301
Title: Efficacy of rivastigmine in subjects with moderately severe Alzheimer's disease.
Journal: International journal of geriatric psychiatry 20040301
Title: Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate.
Journal: Journal of child neurology 20040301
Title: Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging.
Journal: Stroke 20040201
Title: Prediction of treatment response to rivastigmine in Alzheimer's dementia.
Journal: Journal of neurology, neurosurgery, and psychiatry 20040201
Title: Pharmacologic treatment expectations in the management of dementia with Lewy bodies.
Journal: Dementia and geriatric cognitive disorders 20040101
Title: Acetylcholinesterase inhibition in Alzheimer's Disease.
Journal: Current pharmaceutical design 20040101
Title: Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.
Journal: Drugs & aging 20040101
Title: Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies.
Journal: Dementia and geriatric cognitive disorders 20040101
Title: Use of cognitive enhancement medication in persons with Alzheimer disease who have a family caregiver: results from the Resources for Enhancing Alzheimer's Caregiver Health (REACH) project.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20040101
Title: Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a 'real world' study.
Journal: Archives of gerontology and geriatrics. Supplement 20040101
Title: What are the treatment options for patients with severe Alzheimer's disease?
Journal: CNS drugs 20040101
Title: The use, benefits, and costs of cholinesterase inhibitors for Alzheimer's dementia in long-term care: are the data relevant and available?
Journal: Journal of the American Medical Directors Association 20040101
Title: Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration.
Journal: Dementia and geriatric cognitive disorders 20040101
Title: Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20040101
Title: Rivastigmine in Alzheimer disease: efficacy over two years.
Journal: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 20040101
Title: Noncognitive symptoms and long-term treatment expectations for Alzheimer disease.
Journal: Alzheimer disease and associated disorders 20040101
Title: Does rivastigmine improve cognitive functions or disability in patients with Alzheimer's disease?
Journal: Neuroepidemiology 20040101
Title: Differential qualitative responses to rivastigmine in APOE epsilon 4 carriers and noncarriers.
Journal: The pharmacogenomics journal 20040101
Title: Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease.
Journal: Clinical neuropharmacology 20040101
Title: Disease stage in Alzheimer disease and treatment effects of rivastigmine.
Journal: Alzheimer disease and associated disorders 20040101
Title: Rivastigmine in frontotemporal dementia: an open-label study.
Journal: Drugs & aging 20040101
Title: Impact of rivastigmine use on the risk of nursing home placement in a US sample.
Journal: CNS drugs 20040101
Title: The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies.
Journal: The Journal of neuropsychiatry and clinical neurosciences 20040101
Title: Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients.
Journal: American journal of Alzheimer's disease and other dementias 20040101
Title: [The effect of rivastigmine on cognitive functions and regional cerebral blood flow in Alzheimer's disease and vascular dementia: follow-up for 2 years].
Journal: Neurologia i neurochirurgia polska 20040101
Title: The effect of cholinesterase inhibitors on the regional blood flow in patients with Alzheimer's disease and vascular dementia.
Journal: Journal of the neurological sciences 20031215
Title: Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine.
Journal: Brain : a journal of neurology 20031201
Title: A case history illustrating how extended release cholinesterase inhibitors could improve management of Alzheimer's disease.
Journal: Journal of Alzheimer's disease : JAD 20031201
Title: Nightmares without atonia as an early symptom of diffuse Lewy bodies disease.
Journal: Arquivos de neuro-psiquiatria 20031201
Title: Italian drug policy: ethical aims of essential assistance levels.
Journal: Health care analysis : HCA : journal of health philosophy and policy 20031201
Title: Impact of rivastigmine on costs and on time spent in caregiving for families of patients with Alzheimer's disease.
Journal: International psychogeriatrics 20031201
Title: Rivastigmine blocks voltage-activated K+ currents in dissociated rat hippocampal neurons.
Journal: British journal of pharmacology 20031101
Title: Rivastigmine (Exelon) for dementia in patients with Parkinson's disease.
Journal: Acta neurologica Scandinavica 20031101
Title: Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: an open, controlled trial.
Journal: Pharmacopsychiatry 20031101
Title: Potential long-term effects of rivastigmine on disease progression may be linked to drug effects on vascular changes in Alzheimer brains.
Journal: International journal of clinical practice 20031101
Title: [Oestro-progestagen treatment combined with rivastigmine in menopausal women suffering from Alzheimer's disease. The results of a 28-weeks controlled study].
Journal: Presse medicale (Paris, France : 1983) 20031025
Title: Editorial comment--How to treat vascular dementia?
Journal: Stroke 20031001
Title: Role of cholinesterase inhibitor in the management of sexual aggression in an elderly demented woman.
Journal: Journal of the American Geriatrics Society 20030901
Title: [Subcortical vascular encephalopathy].
Journal: Therapeutische Umschau. Revue therapeutique 20030901
Title: Update on rivastigmine.
Journal: The neurologist 20030901
Title: Influence of cholinergic circuitries in generation of high-frequency somatosensory evoked potentials.
Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 20030801
Title: [Acetylcholinesterase inhibitors].
Journal: Revue medicale de la Suisse romande 20030701
Title: Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease.
Journal: Neuroscience letters 20030612
Title: Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.
Journal: The Journal of pharmacology and experimental therapeutics 20030601
Title: The clinical use of P300 event related potentials for the evaluation of cholinesterase inhibitors treatment in demented patients.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20030601
Title: Rivastigmine and QT interval prolongation.
Journal: The British journal of psychiatry : the journal of mental science 20030601
Title: Rivastigmine in prevention of delirium in a 65 years old man with Parkinson's disease.
Journal: International journal of geriatric psychiatry 20030601
Title: Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.
Journal: Archives of neurology 20030601
Title: Comparative study of donepezil and rivastigmine.
Journal: International journal of clinical practice 20030601
Title: A review of rivastigmine: a reversible cholinesterase inhibitor.
Journal: Clinical therapeutics 20030601
Title: Dementia.
Journal: Clinical evidence 20030601
Title: [Current therapy of patients with dementia].
Journal: MMW Fortschritte der Medizin 20030526
Title: Surprising discovery with Alzheimer's medication.
Journal: Drug discovery today 20030501
Title: [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Journal: Nederlands tijdschrift voor geneeskunde 20030405
Title: [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Journal: Nederlands tijdschrift voor geneeskunde 20030405
Title: Effects of rivastigmine on the quantitative EEG in demented Parkinsonian patients.
Journal: Acta neurologica Scandinavica 20030401
Title: [Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
Journal: Fortschritte der Neurologie-Psychiatrie 20030401
Title: Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy.
Journal: International clinical psychopharmacology 20030301
Title: [Tolerance and adverse events of treatment with acetylcholinesterase inhibitors in a clinical sample of patients with very slight and mild Alzheimer s disease over a six-month period].
Journal: Revista de neurologia 20030301
Title: Rivastigmine in the treatment of alcohol-induced persisting dementia.
Journal: The West Indian medical journal 20030301
Title: Cerebral glucose metabolism, cerebrospinal fluid-beta-amyloid1-42 (CSF-Abeta42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients.
Journal: Neuroscience letters 20030227
Title: Quantitative determination of rivastigmine and its major metabolite in human plasma by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030205
Title: Cholinesterase inhibitor rivastigmine enhance the mitochondrial electron transport chain in lymphocytes of patients with Alzheimer's disease.
Journal: Journal of the neurological sciences 20030115
Title: No additional benefit of HRT on response to rivastigmine in menopausal women with AD.
Journal: Neurology 20030114
Title: [Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Journal: Nederlands tijdschrift voor geneeskunde 20030104
Title: Comparative study of donepezil and rivastigmine.
Journal: International journal of clinical practice 20030101
Title: The reduced release of GH by GHRH in 8 subjects aged 65-69 years is augmented considerably by rivastigmine, a drug for Alzheimer's disease.
Journal: Gerontology 20030101
Title: Rivastigmine: an update on therapeutic efficacy in Alzheimer's disease and other conditions.
Journal: Current medical research and opinion 20030101
Title: Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors.
Journal: Current medical research and opinion 20030101
Title: Cholinesterase inhibitors for dementia with Lewy bodies.
Journal: The Cochrane database of systematic reviews 20030101
Title: Current treatments for Alzheimer's disease: cholinesterase inhibitors.
Journal: The Journal of clinical psychiatry 20030101
Title: Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain.
Journal: Acta biologica Hungarica 20030101
Title: Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients.
Journal: American journal of Alzheimer's disease and other dementias 20030101
Title: [Mechanisms of action of Alzheimer medications].
Journal: Duodecim; laaketieteellinen aikakauskirja 20030101
Title: Effects of rivastigmine on cognitive function and quality of life in patients with schizophrenia.
Journal: Clinical neuropharmacology 20030101
Title: Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors.
Journal: Current medical research and opinion 20030101
Title: No donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatment.
Journal: Current medical research and opinion 20030101
Title: Rivastigmine in vascular dementia.
Journal: International psychogeriatrics 20030101
Title: [Early diagnosis and treatment of Alzheimer's disease. Implementation in the doctor's office].
Journal: Fortschritte der Medizin. Originalien 20021205
Title: Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease.
Journal: Journal of neurology, neurosurgery, and psychiatry 20021201
Title: Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
Journal: Journal of clinical psychopharmacology 20021201
Title: Rivastigmine in patients with Alzheimer's disease and concurrent hypertension.
Journal: International journal of clinical practice 20021201
Title: [Ethical aspects of anti-Alzheimer drugs: experiences of caregivers].
Journal: Tijdschrift voor gerontologie en geriatrie 20021201
Title: Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine.
Journal: European journal of pharmacology 20021129
Title: Rivastigmine in subcortical vascular dementia: an open 22-month study.
Journal: Journal of the neurological sciences 20021115
Title: [Rivastigmine: a review of its clinical effectiveness].
Journal: Revista de neurologia 20021101
Title: Rivastigmine in the treatment of Huntington's disease.
Journal: European journal of neurology 20021101
Title: [Anti-dementia drugs for Alzheimer disease in present and future].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20021101
Title: Fatal aspiration pneumonia during transition from donepezil to rivastigmine.
Journal: The Annals of pharmacotherapy 20021001
Title: The impact of journal advertisements on prescribers of cholinesterase inhibitors.
Journal: International journal of geriatric psychiatry 20021001
Title: [Rivastigmine in current clinical practice in patients with mild to moderate Alzheimer's disease].
Journal: Revue neurologique 20020901
Title: Electroconvulsive therapy in a patient receiving rivastigmine.
Journal: The journal of ECT 20020901
Title: Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20020901
Title: Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.
Journal: Neurology 20020827
Title: Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation.
Journal: Neurology 20020813
Title: Clinical use of cholinomimetic agents: a review.
Journal: The Journal of head trauma rehabilitation 20020801
Title: Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20020801
Title: Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20020701
Title: Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats.
Journal: Journal of neural transmission (Vienna, Austria : 1996) 20020701
Title: Medical treatment of Alzheimer's disease: past, present, and future.
Journal: Medicine and health, Rhode Island 20020701
Title: Guidelines for managing Alzheimer's disease: Part II. Treatment.
Journal: American family physician 20020615
Title: Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness.
Journal: Clinical therapeutics 20020601
Title: The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia.
Journal: International journal of clinical practice. Supplement 20020601
Title: Do cholinesterase inhibitors slow progression of Alzheimer's disease?
Journal: International journal of clinical practice. Supplement 20020601
Title: The tolerability and safety of cholinesterase inhibitors in the treatment of dementia.
Journal: International journal of clinical practice. Supplement 20020601
Title: Correlates of dropout, efficacy, and adverse events in treatment with acetylcholinesterase inhibitors in Korean patients with Alzheimer's disease.
Journal: International psychogeriatrics 20020601
Title: Prolonged QT interval with rivastigmine.
Journal: The British journal of psychiatry : the journal of mental science 20020501
Title: Electrocardiographic effects of rivastigmine.
Journal: Journal of clinical pharmacology 20020501
Title: Long-term effects of rivastigmine in moderately severe Alzheimer's disease: does early initiation of therapy offer sustained benefits?
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20020501
Title: Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease.
Journal: Progress in neuro-psychopharmacology & biological psychiatry 20020501
Title: A pilot, randomized, open-label trial assessing safety and pharmakokinetic parameters of co-administration of rivastigmine with risperidone in dementia patients with behavioral disturbances.
Journal: International journal of geriatric psychiatry 20020401
Title: The clinical benefits of rivastigmine may reflect its dual inhibitory mode of action: an hypothesis.
Journal: International journal of clinical practice 20020401
Title: Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine.
Journal: Biochemistry 20020319
Title: [Rivastigmine for Alzheimer disease; evaluation of preliminary results and of structured assessment of efficacy].
Journal: Nederlands tijdschrift voor geneeskunde 20020309
Title: Rivastigmine in outpatient services: experience of 114 neurologists in Austria.
Journal: International clinical psychopharmacology 20020301
Title: Switching cholinesterase inhibitor therapy in Alzheimer's disease--donepezil to rivastigmine, is it worth it?
Journal: International journal of geriatric psychiatry 20020301
Title: Understanding changes in cholinergic function: implications for treating dementia.
Journal: The Journal of clinical psychiatry 20020301
Title: Rivastigmin and impaired motor function.
Journal: Pharmacopsychiatry 20020301
Title: [Cognitive rehabilitation in Alzheimer's disease patients: multidisciplinary team report].
Journal: Arquivos de neuro-psiquiatria 20020301
Title: Synthesis and cholinesterase activity of phenylcarbamates related to Rivastigmine, a therapeutic agent for Alzheimer's disease.
Journal: European journal of medicinal chemistry 20020201
Title: An open-label study to evaluate the safety, tolerability and efficacy of rivastigmine in patients with mild to moderate probable Alzheimer's disease in the community setting.
Journal: Medical science monitor : international medical journal of experimental and clinical research 20020201
Title: Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease.
Journal: Neuroreport 20020121
Title: [Rivastigmine for Alzheimer disease; evaluation of preliminary results and of structured assessment of efficacy].
Journal: Nederlands tijdschrift voor geneeskunde 20020105
Title: Advances in the treatment of Alzheimer's disease: benefits of dual cholinesterase inhibition.
Journal: European neurology 20020101
Title: Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system.
Journal: Dementia and geriatric cognitive disorders 20020101
Title: In vitro toxicity of rivastigmine and donepezil in cells of epithelial origin.
Journal: Ophthalmic research 20020101
Title: Estimation of the absolute bioavailability of rivastigmine in patients with mild to moderate dementia of the Alzheimer's type.
Journal: Clinical pharmacokinetics 20020101
Title: Cutaneous drug reaction case reports: from the world literature.
Journal: American journal of clinical dermatology 20020101
Title: Centrally acting antiemetics mitigate nausea and vomiting in patients with Alzheimer's disease who receive rivastigmine.
Journal: Clinical neuropharmacology 20020101
Title: Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil.
Journal: Current medical research and opinion 20020101
Title: Understanding and managing behavioural symptoms in Alzheimer's disease and related dementias: focus on rivastigmine.
Journal: Current medical research and opinion 20020101
Title: Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.
Journal: Clinical pharmacokinetics 20020101
Title: Cholinesterase inhibitors in Alzheimer's disease: donepezil or rivastigmine?
Journal: International journal of clinical practice 20020101
Title: A multinational, randomised, 12-week, comparative study of donepezil and rivastigmine in patients with mild to moderate Alzheimer's disease.
Journal: International journal of clinical practice 20020101
Title: Rivastigmine antagonizes deficits in prepulse inhibition induced by selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis.
Journal: Neuroscience 20020101
Title: Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series.
Journal: Current medical research and opinion 20020101
Title: Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review.
Journal: International journal of technology assessment in health care 20020101
Title: Comments on Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil.
Journal: Current medical research and opinion 20020101
Title: Worsening of motor function and mood in a patient with Parkinson's disease after pharmacologic challenge with oral rivastigmine.
Journal: Clinical neuropharmacology 20020101
Title: A clinical overview of cholinesterase inhibitors in Alzheimer's disease.
Journal: International psychogeriatrics 20020101
Title: [Acetylcholinesterase inhibitors--beyond Alzheimer's disease].
Journal: Psychiatria polska 20020101
Title: Testosterone mediates sex difference in hypothermia and cholinesterase inhibition by rivastigmine.
Journal: European journal of pharmacology 20011214
Title: [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
Journal: MMW Fortschritte der Medizin 20011213
Title: [Perspectives for drug treatment in Alzheimer's disease].
Journal: Annales de medecine interne 20011201
Title: [A comparison of cholinesterase inhibitors and ginkgo extract in treatment of Alzheimer dementia].
Journal: Fortschritte der Medizin. Originalien 20011129
Title: Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina.
Journal: Mechanisms of ageing and development 20011101
Title: Erythematous maculopapular eruption due to rivastigmine therapy.
Journal: The American journal of medicine 20011101
Title: Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial.
Journal: Movement disorders : official journal of the Movement Disorder Society 20011101
Title: Adverse reactions to rivastigmine in three cases of dementia.
Journal: The Australian and New Zealand journal of psychiatry 20011001
Title: Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's disease.
Journal: Journal of clinical pharmacology 20011001
Title: Acetylcholinesterase inhibitor SDZ ENA 713 (Rivastigmine) increases brain pyrrolidone carboxyl peptidase activity.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20011001
Title: Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease.
Journal: The international journal of neuropsychopharmacology 20010901
Title: [Anticholinesterase agents in Alzheimer's disease].
Journal: Revue medicale de Bruxelles 20010901
Title: Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep.
Journal: International psychogeriatrics 20010901
Title: Peripheral and dual binding site acetylcholinesterase inhibitors: implications in treatment of Alzheimer's disease.
Journal: Mini reviews in medicinal chemistry 20010901
Title: Effects of ENA713 and CHF2819, two anti-Alzheimer's disease drugs, on rat amino acid levels.
Journal: Brain research 20010810
Title: Medications for the treatment of Alzheimer's disease.
Journal: The Journal of the Oklahoma State Medical Association 20010801
Title: Maintaining functional and behavioral abilities in Alzheimer disease.
Journal: Alzheimer disease and associated disorders 20010801
Title: Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up.
Journal: European journal of neurology 20010701
Title: Use of cholinesterase inhibitors for treatment of Alzheimer disease.
Journal: Cleveland Clinic journal of medicine 20010701
Title: Featured CME topic: dementia. Medication update.
Journal: Southern medical journal 20010701
Title: Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial.
Journal: International psychogeriatrics 20010601
Title: Rivastagmine-induced agitation following transient recollection of autobiographical memory.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20010601
Title: Review of rivastigmine and its clinical applications in Alzheimer's disease and related disorders.
Journal: Expert opinion on pharmacotherapy 20010401
Title: Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression.
Journal: Archives of neurology 20010301
Title: Spontaneous rupture of oesophagus (Boerhaave's syndrome) related to rivastigmine.
Journal: Age and ageing 20010301
Title: [Evaluation of the therapeutic effects in individual patients with Alzheimer disease].
Journal: Nederlands tijdschrift voor geneeskunde 20010224
Title: Successful treatment of nonanticholinergic delirium with a cholinesterase inhibitor.
Journal: Journal of clinical psychopharmacology 20010201
Title: Brief review: rivastigmine, a second cholinesterase inhibitor.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20010201
Title: Cholinesterase inhibitors for Alzheimer's disease.
Journal: Drugs 20010101
Title: Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.
Journal: Health technology assessment (Winchester, England) 20010101
Title: Donepezil, rivastigmine, and vitamin E in Alzheimer disease: a combined P300 event-related potentials/neuropsychologic evaluation over 6 months.
Journal: Clinical neuropharmacology 20010101
Title: Rivastigmine. A pharmacoeconomic review of its use in Alzheimer's disease.
Journal: PharmacoEconomics 20010101
Title: Short-term rivastigmine treatment reduces EEG slow-wave power in Alzheimer patients.
Journal: Neuropsychobiology 20010101
Title: Pharmacokinetic profiles of current therapies for Alzheimer's disease: implications for switching to galantamine.
Journal: Clinical therapeutics 20010101
Title: [Current strategies of pathogenetic therapy of Alzheimer's disease].
Journal: Vestnik Rossiiskoi akademii meditsinskikh nauk 20010101
Title: Rivastigmine in the treatment of Alzheimer's disease.
Journal: European neurology 20010101
Title: Evaluation of cholinergic treatment in demented patients by P300 evoked related potentials.
Journal: Neurologia i neurochirurgia polska 20010101
Title: Drugs used for cognitive symptoms of Alzheimer's disease.
Journal: Perspectives in psychiatric care 20010101
Title: Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists.
Journal: Japanese journal of pharmacology 20001001
Title: Relation between cholinesterase inhibitor and Pisa syndrome.
Journal: Lancet (London, England) 20000624
Title: Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.
Journal: BMJ (Clinical research ed.) 19990306
Title: Qian-Sheng Yu, et al. Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines. J Med Chem. 2002 Aug 15;45(17):3684-91.
Title: Han HJ, Lee JJ, Park SA et al. Efficacy and safety of switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch in patients with probable Alzheimer's disease. J Clin Neurol. 2011 Sep;7(3):137-42.
Title: Helena Shifrin, et al. Rivastigmine alleviates experimentally induced colitis in mice and rats by acting at central and peripheral sites to modulate immune responses. PLoS One. 2013;8(2):e57668.
Title: Raafat A Abdel-Aal, et al. Rivastigmine reverses aluminum-induced behavioral changes in rats. Eur J Pharmacol. 2011 Jun 1;659(2-3):169-76.
